CFTR and cystic fibrosis: In this study, we evaluated an off-label Vx-809 use, hypothesizing that probably it does not interact directly with the mutant CFTR protein, responsible for cystic fibrosis, but with a yet unknown mechanism that acts indirectly on misfolded proteins, thus preventing the triggering of mechanisms involved in ER stress.